| review article | Q7318358 |
| scholarly article | Q13442814 |
| P2093 | author name string | Walter H Reinhart | |
| P2860 | cites work | Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial | Q27860743 |
| Secondary prevention by raising HDL cholesterol and reducing triglycerides in patients with coronary artery disease | Q28139910 | ||
| Mutation in the promoter region of the beta-fibrinogen gene and the risk of future myocardial infarction, stroke and venous thrombosis | Q28191812 | ||
| Cardiovascular disease outcomes during 6.8 years of hormone therapy: Heart and Estrogen/progestin Replacement Study follow-up (HERS II) | Q28193306 | ||
| Acute-phase proteins and other systemic responses to inflammation | Q28296941 | ||
| Genes encoding fibrinogen and cardiovascular risk | Q34441548 | ||
| Association of fibrinogen, C-reactive protein, albumin, or leukocyte count with coronary heart disease: meta-analyses of prospective studies | Q34469221 | ||
| Interactions of intercellular adhesion molecule-1 with fibrinogen | Q34635635 | ||
| Extracorporeal fibrinogen adsorption--efficacy, selectivity and safety in healthy subjects and patients with foot ulcers | Q34647605 | ||
| Prediction of stroke in the general population in Europe (EUROSTROKE): Is there a role for fibrinogen and electrocardiography? | Q35576134 | ||
| Fibrinogen deficiency reduces vascular accumulation of apolipoprotein(a) and development of atherosclerosis in apolipoprotein(a) transgenic mice | Q36527433 | ||
| Fibrinogen deficiency is compatible with the development of atherosclerosis in mice | Q37379082 | ||
| Hemostatic factors and the risk of myocardial infarction or sudden death in patients with angina pectoris. European Concerted Action on Thrombosis and Disabilities Angina Pectoris Study Group | Q39522420 | ||
| Platelet glycoprotein IIb/IIIa receptors in cardiovascular medicine | Q40518648 | ||
| Therapeutic interventions to lower plasma fibrinogen concentration | Q40553954 | ||
| A prospective study of fibrinogen and risk of myocardial infarction in the Physicians' Health Study | Q40818460 | ||
| Novel risk factors for systemic atherosclerosis: a comparison of C-reactive protein, fibrinogen, homocysteine, lipoprotein(a), and standard cholesterol screening as predictors of peripheral arterial disease | Q43614603 | ||
| Fibrinogen: associations with cardiovascular events in an outpatient clinic | Q43770590 | ||
| A prospective study of plasma fibrinogen levels and the risk of stroke among participants in the bezafibrate infarction prevention study | Q43787052 | ||
| A pharmacoepidemiological assessment of the effect of statins and fibrates on fibrinogen concentration | Q43833293 | ||
| Severe hypertriglyceridemia with insulin resistance is associated with systemic inflammation: reversal with bezafibrate therapy in a randomized controlled trial | Q43917196 | ||
| Physical activity and hemostatic and inflammatory variables in elderly men. | Q43961149 | ||
| Different associations of C-reactive protein, fibrinogen and C3 with traditional risk factors in middle-aged men. | Q43963234 | ||
| Effects of hyperfibrinogenemia on vasculature of C57BL/6 mice with and without atherogenic diet | Q44275944 | ||
| Prospective study of markers of hemostatic function with risk of ischemic stroke. The Atherosclerosis Risk in Communities (ARIC) Study Investigators | Q48134376 | ||
| Elevated plasma fibrinogen: cause or consequence of cardiovascular disease? | Q50894445 | ||
| Fibrinogen and risk of cardiovascular disease. The Framingham Study. | Q52588834 | ||
| The relationship between attendance at religious services and cardiovascular inflammatory markers. | Q53441808 | ||
| Vasoactive effects of fibrinogen on saphenous vein | Q56891683 | ||
| Hyperfibrinogenemia Is Associated With Specific Histocytological Composition and Complications of Atherosclerotic Carotid Plaques in Patients Affected by Transient Ischemic Attacks | Q58492246 | ||
| P433 | issue | 3 | |
| P304 | page(s) | 211-216 | |
| P577 | publication date | 2003-01-01 | |
| P1433 | published in | Vascular Medicine | Q7916445 |
| P1476 | title | Fibrinogen--marker or mediator of vascular disease? | |
| P478 | volume | 8 |
| Q52915425 | Anti-inflammatory, Antithrombotic and Cardiac Remodeling Preventive Effects of Eugenol in Isoproterenol-Induced Myocardial Infarction in Wistar Rat. |
| Q53640161 | Association of increased fibrinogen concentration with impaired activation of anticoagulant protein C. |
| Q50240094 | Atomic force microscopy as a tool to evaluate the risk of cardiovascular diseases in patients |
| Q57134677 | Chronic Stress in Children and Adolescents: A Review of Biomarkers for Use in Pediatric Research |
| Q33729553 | Clinical correlation between N-terminal pro-B-type natriuretic peptide and angiographic coronary atherosclerosis |
| Q35019922 | Consolidated and emerging inflammatory markers in coronary artery disease |
| Q38044961 | Cryoprecipitate: an outmoded treatment? |
| Q54430137 | Determinants of risk factors of atherosclerosis in the postinfarction period: the Tallinn MI study. |
| Q98386867 | Dynamic functional clot formation in patients undergoing endoscopic mucosal resection |
| Q37115819 | Emerging families of biomarkers for coronary artery disease: inflammatory mediators |
| Q33532288 | Fibrinogen beta variants confer protection against coronary artery disease in a Greek case-control study |
| Q85193685 | Fibrinogen concentrate for management of bleeding |
| Q36204158 | Fibrinogen excretion in the urine and immunoreactivity in the kidney serves as a translational biomarker for acute kidney injury |
| Q36679150 | Fibrinogen levels in trauma patients during the first seven days after fibrinogen concentrate therapy: a retrospective study |
| Q37738172 | Fibrinogen plasma concentration is an independent marker of haemodynamic impairment in chronic thromboembolic pulmonary hypertension |
| Q28573774 | Fibrinogen β-derived Bβ(15-42) peptide protects against kidney ischemia/reperfusion injury |
| Q28393721 | Gene polymorphisms in association with emerging cardiovascular risk markers in adult women |
| Q37266804 | Haemostatic markers are associated with measures of vascular disease in adults with hypertension |
| Q34429646 | Heterozygosity for fibrinogen results in efficient resolution of kidney ischemia reperfusion injury |
| Q35025400 | Inflammation, kidney function and albuminuria in the Framingham Offspring cohort |
| Q31127055 | Modeling a hydropic recipient twin in twin-twin transfusion syndrome |
| Q79822450 | One-month therapy with simvastatin restores endothelial function in hypercholesterolemic children and adolescents |
| Q26796205 | Over 50 Years of Fibrinogen Concentrate |
| Q84934992 | Plasma fibrinogen levels and restenosis after primary percutaneous coronary intervention |
| Q35835815 | Plasma fibrinogen lever and risk of coronary heart disease among Chinese population: a systematic review and meta-analysis |
| Q52854977 | Raised plasma fibrinogen concentration in patients with abdominal aortic aneurysm. |
| Q92277332 | Relationship Between the Reciprocal Change in Inflammation-Related Biomarkers (Fibrinogen-to-Albumin and hsCRP-to-Albumin Ratios) and the Presence and Severity of Coronary Slow Flow |
| Q49787716 | Relationships of oxidized HDL with blood coagulation and fibrinolysis in patients with type 2 diabetes mellitus |
| Q80161407 | Simulating fibrin clotting time |
| Q36652513 | The Effect of a Single Bout Circuit Resistance Exercise on Homocysteine, hs-CRP and Fibrinogen in Sedentary Middle Aged Men |
| Q42961174 | The NF-κB pathway: regulation of the instability of atherosclerotic plaques activated by Fg, Fb, and FDPs |
| Q36808026 | The role of established and emerging risk factors in peripheral vascular graft occlusion |
| Q36854348 | Time course of haemostatic effects of fibrinogen concentrate administration in aortic surgery |
| Q33652908 | Whole and refined grain intakes are related to inflammatory protein concentrations in human plasma |
Search more.